Why Beijing could block the SpaceX-Tesla merger

More in Business

• General Dynamics tops quarterly estimates on robust Gulfstream, marine bookings

  Strong commercial aerospace and defense contracting demand enabled the company to outpace Wall Street expectations for the recent period. Robust customer commitments across both the private aviation line and naval manufacturing units drove this outperformance. These order volumes indicate sustained operational momentum across both civil and defense markets.

  1 min read
• STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more

  Major pharmaceutical manufacturers are navigating operational setbacks and shifting market dynamics across multiple global markets. AstraZeneca is overhauling its balance sheet to counteract revenue losses from impending patent expirations on key treatments, while Sun Pharmaceutical faces severe manufacturing disruptions at a vital production facility. These developments highlight the pressure on drugmakers to balance aggressive pipeline reinvestment with strict regulatory compliance.

  2 min read
• NTPC Green Energy Q2 Results: Profit jumps 56% YoY to Rs 137 crore, revenue rises 53%

  Strong operational expansion and improved margins drove solid quarterly performance despite a concurrent rise in overall corporate expenses. Additional solar capacity commissioned in Rajasthan reinforced the utility's renewable infrastructure footprint. However, investor enthusiasm remained muted on the public markets as the company's shares extended their year-to-date downtrend.

  2 min read